Vagus Nerve Stimulator implantation in a pregnant woman with drug resistant epilepsy
M. N. Klochkov,
S. A. Katyshev,
A. V. Vtorov,
M. M. Bondareva,
T. A. Skoromets,
A. G. Naryshkin,
A. A. Feygina https://doi.org/10.17749/2077-8333.2019.11.4.388-394
Abstract
The aim is to present a case of successful implantation of Vagus Nerve Stimulator (VNS) in a woman with drug resistant epilepsy (DRE) during pregnancy. It is the first case of VNS implantation in the Russian Federation. The implantation, follow-up, and programming were carried out in the Bekhterev National Research Medical Centre of Psychiatry and Neurology, Saint-Petersburg.
Material and method. Female patient, 28 y.o., was diagnosed with DRE more than 11 years ago. The course of her epilepsy deteriorated during pregnancy despite of the appropriate antiepileptic treatment. The EEG, MRI, and laboratory tests did not reveal any focal brain lesion that could necessitate surgical resection. After multidisciplinary consultations, no contraindications to VNS procedure were found.
Results. The VNS system was implanted in this patient when she was 18-week-pregnant. The procedure resulted in a seizure reduction and allowed the patient to preserve her pregnancy and deliver a healthy child.
Conclusions. VNS Therapy® is safe and effective for the treatment of DRE. This successful case of VNS implantation in pregnancy opens new venues for the treatment of DRE in this group of patients.
The authors declare the absence of conflict of interest with respect to this publication. All authors contributed equally to this article.
About the Authors
M. N. Klochkov
Bekhterev National Medical Research Center of Psychiatry and Neurology
Russian Federation
Michael N. Klochkov – MD, Neurologist, Department of Neurosurgery
Russian Federation
Michael N. Klochkov – MD, Neurologist, Department of Neurosurgery
S. A. Katyshev
Bekhterev National Medical Research Center of Psychiatry and Neurology
Russian Federation
Sergey A. Katyshev – MD, Neurosurgeon & Psychiatrist, Department of Neurosurgery
Russian Federation
Sergey A. Katyshev – MD, Neurosurgeon & Psychiatrist, Department of Neurosurgery
A. V. Vtorov
Bekhterev National Medical Research Center of Psychiatry and Neurology
Russian Federation
Alexander V. Vtorov – MD, Head of the Department of Neurosurgery
Russian Federation
Alexander V. Vtorov – MD, Head of the Department of Neurosurgery
M. M. Bondareva
Bekhterev National Medical Research Center of Psychiatry and Neurology
Russian Federation
Maria M. Bondareva – MD, Junior Researcher, Department of Neurosurgery
Russian Federation
Maria M. Bondareva – MD, Junior Researcher, Department of Neurosurgery
T. A. Skoromets
Bekhterev National Medical Research Center of Psychiatry and Neurology
Russian Federation
Taras A. Skoromets – MD, PhD, Chief Researcher & Supervisor, Department of Neurosurgery
Russian Federation
Taras A. Skoromets – MD, PhD, Chief Researcher & Supervisor, Department of Neurosurgery
A. G. Naryshkin
Bekhterev National Medical Research Center of Psychiatry and Neurology;
Sechenov Institute of evolutionary physiology and biochemistry Russian Academy of Sciences;
Mechnikov Northwestern State Medical University
Russian Federation
Alexander G. Naryshkin – MD, PhD, Leading Researcher, Department of Neurosurgery, Bekhterev National Medical Research Center of Psychiatry and Neurology; Leading Researcher, Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences; Professor at the Polenov Department of Neurosurgery,
Russian Federation
Alexander G. Naryshkin – MD, PhD, Leading Researcher, Department of Neurosurgery, Bekhterev National Medical Research Center of Psychiatry and Neurology; Leading Researcher, Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences; Professor at the Polenov Department of Neurosurgery,
A. A. Feygina
LLC “Sorin Group Rus”, official representative “LivaNova” in Russia
Russian Federation
Anna A. Feygina – MD, PhD, Neurologist, Medical Science Liaison Manager, Neuromodulation, Russia, LLC “Sorin Group Rus”, Authorized Representative of “LivaNova”.
Russian Federation
Anna A. Feygina – MD, PhD, Neurologist, Medical Science Liaison Manager, Neuromodulation, Russia, LLC “Sorin Group Rus”, Authorized Representative of “LivaNova”.
References
1. Alexopoulos A.V. Epileptology. 2013; 1: 138-42.
2. Kwan P., Arzimanoglou A., Berg A.T., Brodie M.J., Allen Hauser W., Mathern G., Moshé S.L., Perucca E., Wiebe S., French J. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010; 51: 1069-77.
3. Kwan P., Brodie M.J. Early identification of refractory epilepsy. New Engl J Med. 2000; 342: 314-9.
4. Kwan P. Epigraph vol. 20, issue 1, summer 2018.
5. A guide for the doctor. VNS therapy system. 2016 (in Russ.)
6. National leadership. Psychiatry. Edited by Yu.A. Alexandrovsky, N.G. Neznanov. 2018; s. 992. (in Russ).
7. Patel S.I., Pennell P.B. Management of epilepsy during pregnancy: an update. Ther Adv Neurol Disord. 2016 Mar; 9 (2): 118-129.
8. Abe K., Hamada H., Yamada T., et al. Impact of planning of pregnancy in women with epilepsy on seizure control during pregnancy and on maternal and neonatal outcomes. Seizure. 2014; 23: 112-6.
9. Heather G.H., Ramage-Morin P., Wong S.L. Epilepsy in Canada: prevalence and impact. Epilepsy in Canada: prevalence and impact. Health Matters. Health Reports. 2016; 27: 24-30.
10. Creasy R., Resnik R., Iams J., Lockwood C., Moore T., editors. Creasy Resnik’s Maternal-fetal medicine: principles and practice. 6th ed. Philadelphia (PA): Elsevier; 2009.
11. Battino D, Tomson T. Management of epilepsy during pregnancy. Drugs. 2007; 67: 2727-46.
12. Perucca E. Birth defects after prenatal exposure to antiepileptic drugs. Lancet Neurol. 2005; 4: 781- 6.
13. Elliott R.E., Morsi A., Kalhorn S.P., Marcus J., Sellin J., Kang M., Silverberg A., Rivera E., Geller E., Carlson C, Devinsky O., Doyle W.K. Vagus nerve stimulation in 436 consecutive patients with treatmentresistant epilepsy: long-term outcomes and predictors of response. Epilepsy Behav. 2011 Jan; 20 (1): 57-63.
14. Ben-Menachem B., Ristanovic R., Murphy J. Gestational outcomes in patients with epilepsy receiving vagus nerve stimulation. Epilepsia. 1998; 39 (6): 180.
15. Salerno G., Passamonti C., Cecchi A., Zamponi N. Vagus nerve stimulation during pregnancy: an instructive case. Childs Nerv Syst. 2016 Jan; 32 (1): 209-11.
16. Husain M.M., D Stegman K. Trevino. Pregnancy and delivery while receiving vagus nerve stimulation for the treatment of major depression: a case report. Ann Gen Psychiatry. 2005; 4: 16.
17. Rodríguez-Osorio X., López-González F.J., Garamendi Í., Rumià J., Matute A., Prieto-González Á., Carreño M. VNS and pregnancy: A multicentric experience of four cases. Acta Neurol Scand. 2017 Oct; 136 (4): 372-374.
18. Marti A.S., Mirsattari S.M., Steven D.A., Parrent A.G., MacDougall K.W., McLachlan R.S., Burneo J.G. Experience on the use of Vagus Nerve Stimulation during pregnancy. Epilepsy research. 2019 October; 156: 106186.
19. Jazebi N., Moghimi N., Lall R., Osadebey E., Ortega-Barnett J., Masel T. Successful implantation and immediate activation of Vagus Nerve Stimulation (VNS) during pregnancy in a patient with intractable epilepsy: A case illustration and review of the literature. J Clin Neurosci. 2017 Aug; 42: 114-115.
Review
For citations:
Klochkov M.N., Katyshev S.A., Vtorov A.V., Bondareva M.M., Skoromets T.A., Naryshkin A.G., Feygina A.A. Vagus Nerve Stimulator implantation in a pregnant woman with drug resistant epilepsy. Epilepsy and paroxysmal conditions. 2019;11(4):388-394. (In Russ.) https://doi.org/10.17749/2077-8333.2019.11.4.388-394
Views: 858
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
